Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide

Biological Psychiatry

Volumn 41, Issue 12, 1997, Pages 1156-1164

  Little, Karley Y ^a,b,g   McLauglin, Daniel P ^a,c   Ranc, Jean ^d   Gilmore, John ^d   Lopez, Juan F ^a,c   Watson, Stanley J ^a,c   Carroll, F Ivy ^e   Butts, John D ^f  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e RTI INTERNATIONAL   (United States)

^f Office of the Chief Medical Examiner   (United States)

^g Ann Arbor VAMC   (United States)

Author keywords

125I RTI 55; Major depression; Postmortem; Serotonin transporter; Suicide

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; MESSENGER RNA; SEROTONIN;

ADULT; AGED; ARTICLE; AUTOPSY; BINDING SITE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; SUICIDE;

ADULT; AGED; AUTORADIOGRAPHY; BINDING SITES; BRAIN CHEMISTRY; CARRIER PROTEINS; COCAINE; DEPRESSIVE DISORDER; FEMALE; HUMANS; IN SITU HYBRIDIZATION; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PSYCHIATRIC STATUS RATING SCALES; RADIOLIGAND ASSAY; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE;

EID: 0030914419     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00301-0     Document Type: Article

References (54)

1. Amara SG, Kuhar MJ (1993): Neurotransmitter transporters: Recent progress. Ann Rev Neurosci 16:73-93.
2. Andersson A, Eriksson A, Marcusson J (1992): Unaltered number of brain serotonin uptake sites in suicide victims. J Psychopharmacol 6:509-513.
3. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995): Localized alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:121-133.
4. Arato M, Tekes K, Tothfalusi L, et al (1991): Reversed hemispheric asymmetry of imipramine binding in suicide victims. Biol Psychiatry 29:699-702.
5. 3H]Imipramine binding in the frontal cortex of suicides. Psychiatry Res 30:125-135.
6. Austin MC, Bradley CC, Mann JJ, Blakely RD (1994): Expression of serotonin transporter messenger RNA in the human brain. J Neurochem 62:2362-2367.
7. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
8. Crow TJ, Cross AJ, Cooper SJ, et al (1984): Neurotransmitter receptors and monoamine metabolites in the brains of patients with alzheimer-type dementia and depression, and suicides. Neuropharmacoloby 23(12B):1561-1569.
9. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ and Sutcliffe JG (1988): p1B15: a cDNA clone of the rat mRNA encoding cyclophilin: DNA 7:261-267.
10. 3H]imipramine. J Pharmacol Exp Ther 242:364-371.
11. 3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patters. Brain Res 591:181-197.
12. Duvernoy HM (1988): The Human Hippocampus, Munich: Bergamnn erlag.
13. Ellis PM, Salmond C (1994): Is platelet imipramine binding reduced in depression? a meta-analysis. Biol Psychiatry 36:292-299.
14. Emouf D, Compagnon P, Lothion P, Narcisse G, Bernard JY, Daoust M (1993): Platelets 3H 5-HT uptake in descendants from alcoholic patients: a potential risk factor for alcohol dependence. Life Sci 52:989-995.
15. Ferrier IN, McKeith IG, Cross AJ, Perry EK, Candy JM, Perry RH (1986): Postmortem neurochemical studies in depression. Ann NY Acad Sci:128-141.
16. Gilbert JM, Brown BA, Bird ED, Marotta CA (1981): The preparation of biologically active mRNA from human post-mortem tissue. J Neurochemistry 36:976-984.
17. Graham D, Esnaud H, Habert E, Langer SZ (1989): A common binding site for tricyclic and nontricyclic 5-hydroxtryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine. Biochem Pharmacol 38(21):3819-3826.
18. Gross-Isseroff R, Israeli M, Biegon A (1989): Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: Effects of suicide. Arch Gen Psychiatry 46: 237-241.
19. Kobayashi H, Sakikkura K, Tsuji S (1990): Stability of mRNA in postmortem human brains. J Mol Neurosci 2:29-34.
20. 125I]iodphenyl)tropane-2β-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions. J Neurochem 62:978-986.
21. 3H]paroxetine, in antidepressant-free depressed suicides. Brain Res 526:17-22.
22. 3H]paroxetine in post mortem human brain from controls and suicides. Biol Psychiatry 28:544-546.
23. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993): Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31-35.
24. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983): Low cerebrospinal fluid 5-HIAA concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33:2609-2614.
25. 125I]RTI-55 binding to cocaine-specific dopaminergic and serotonergic uptake sites in the human brain. J Neurochem 61:1996-2006.
26. 3H]WIN 35428 binding sites in human striatum. Brain Res 628:17-25.
27. 125I]RTI-121 binding sites in human striatum and medial temporal lobe. J Pharmacol Exp Ther 274:1473-1483.
28. Lopez JF, Chalmers DT, Vazquez DM, Watson SJ, Akil H (1994): Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35:287-290.
29. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ (1990): Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis. J Neurosci 10:2587-2600.
30. Marcusson JO, Andersson A, Backstrom I (1989): Drug inhibition indicates a single-site model of the 5-HT uptake site/ antidepressant binding site in rat and human brain. Psychopharmacol 99:17-21.
31. Melikian HE, Moore KR, Oian Y, et al (1993): Structure and function of plasma membrane serotonin transporters. Soc Neurosci Abs 19:494.
32. Meltzer HY, Lowy MT (1987): The serotonin hypothesis of depression. In Meltzer HY (ed), Psychopharmacology. New York: Raven Press, pp 513-526.
33. Mengod G, Charli JL, Palacios JM (1990): The use of in situ hybridization histochemistry for the study of gene expression in the human brain. Cell Mol Neurobiol 19:113.
34. Meyerson LR, Wennogle LP, Abel MS, et al (1982): Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav 17:159-163.
35. 3H]imipramine and the serotonin transporter in human platelets. J Neurochem 48: 560-565.
36. 125I]RTI-55 binding to recombinant human serotonin and dopamine transporters expressed in mammalian cell lines. Soc Neurosci Abs 20:293.
37. Nevo I, Hamon M (1995): Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 26:305-336.
38. Olszewski J, Baxter D (1982): Cytoarchitecture of the Human Brain Stem, 2nd ed. Basel: Cawger.
39. Owen F, Chambers DR, Cooper SJ, et al (1986): Serotonergic mechanisms in brains of suicide victims. Brain Res 362:185-188.
40. Owens MJ, Nemeroff CB (1994): Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40:288-295.
41. Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH (1983): Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 142:188-192.
42. 3H]paroxetine binding to platelet and neuronal membranes. Eur J Pharmacol 119:1-8.
43. Rausch JL, Monteiro MG, Schuckit MA (1991): Platelet serotonin uptake in men with family histories of alcoholism. Neuropsychopharmacology 4:83-86.
44. 3H]imipramine in mouse cerebral cortex. Biochem Pharmacol 33: 4101-4104.
45. Rich CL, Young D, Fowler RC (1986): San Diego suicide study: Young vs old subjects. Arch Gen Psychiatry 43:577-582.
46. 3H]carboxymethoxy-3β-(4-fluorophenyl)tropane to the serotonin transporter. Mol Pharmacol 40:421-426.
47. Segonzac A, Schoemaker H, Langer SZ (1987): Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: A clue to the imipramine selectivity paradox. J Neurochem 48:331-339.
48. Shank RP, Vaught JL, Pelley KA, Setler PE, McComsey DF, Maryanoff BE (1988): McN-5652: A highly potent inhibitor of serotonin uptake. J Pharmacol Exp Ther 247:1032-1038.
49. Staley JK, Hearn L, Ruttenber J, Wetli CV, Mash DC (1994): High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 271:1678-1685.
50. Stanley M, Virgilio J, Gershon S (1982): Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339.
51. Thompson WD, Orvaschel, Prusoff BA, Kidd KK (1982): An evaluation of the family history method for ascertaining psychiatric disorders. Arch Gen Psychiatry 39:53-59.
52. Tork I, Hornung JP (1990): In Paxinos G (ed), The Human Nervous System. New York: Academic Press, pp 1001-1022.
53. 125I]iodphenyl)tropane binding. Mol Pharmacol 43:264-270.
54. 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:1121-1130.